Pura Vida Investments’s Immunogen Inc IMGN Stock Holding History

Pura Vida Investments’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-325,000	Closed	-$2.41M	–	298
2021 Q4	$2.41M	Sell	325,000 -772,500	-70%	-$4.8M	0.09%	142
2021 Q3	$6.22M	Buy	1,097,500 +609,800	+125%	+$3.52M	0.19%	131
2021 Q2	$3.21M	Buy	+487,700	New	+$3.4M	0.1%	138
2019 Q2	–	Sell	-524,600	Closed	-$1.42M	–	134
2019 Q1	$1.42M	Buy	524,600 +31,200	+6%	+$135K	0.2%	87
2018 Q4	$2.37M	Buy	493,400 +293,400	+147%	+$1.78M	0.47%	39
2018 Q3	$1.89M	Buy	+200,000	New	+$1.92M	0.4%	65

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's IMGN Position: Q1 2023 in Review

Pura Vida Investments sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 50,000 shares — an estimated $248K sold.

Pura Vida Investments first reported a position in IMGN in Q4 2020 and held it in 6 quarters. The position peaked at $6.51M in Q1 2021. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

Pura Vida Investments reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 50,000 Immunogen Inc shares in Q1 2023, an estimated $248K.
Pura Vida Investments first reported a position in Immunogen Inc in Q4 2020 and held it in 6 quarters.
Pura Vida Investments's Immunogen Inc position peaked at $6.51M in Q1 2021.
190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.